Measure Description
Percentage of Patients Who Were Not Concurrently Prescribed Opioid Analgesic and Benzodiazepine Medications
Denominator
- Any patient ≥ 18 years of age evaluated by the Eligible Professional
- Transferred, eloped or AMA patients are excluded (V0700)
Numerator
Patients Who Were Concurrently Prescribed Opioid Analgesic and Benzodiazepine Medications
- Performance Met (VE278): Opioid Analgesic AND Benzodiazepine NOT concurrently prescribed during same encounter
- Medical Performance Exclusion (Denominator Exception) (VE279): Patients chronically managed on both benzodiazepines and/or opioids and at risk for withdrawal; cancer patients; patients on hospice care; patients receiving Medically-Assisted Therapy (MAT) with Buprenorphine, Methadone, etc.
- Performance Not Met (VE280): Opioid Analgesic AND Benzodiazepine concurrently prescribed during same encounter, reason not specified
Numerator Exclusions
None
NQF ID Number
N/A
NQS Domain
Effective Clinical Care
High Priority Measure
Yes
Includes Telehealth?
Yes
Inverse Measure
No
Proportional Measure
Yes
Continuous Variable Measure
No
Ratio Measure
No
Number of performance rates to be calculated and submitted
1
Risk-Adjusted Status?
No
Meaningful Measure
Prevention and Treatment of Opioid and Substance Use Disorders
Measure Type
Process
Care Settings
Multiple Care Settings